Offers and News
Visia Complexion Analysis
See what’s really going on with your skin
Schedule a complimentary Visia Complexion Skin Analysis (regular price $150) with our new senior medical aesthetician and receive 15% off suggested skin care products + 15% off individual aesthetic treatments.
15% off for you and a friend
Refer a new client to enjoy an aesthetic service (minimum aesthetic treatment value of $200) and receive 15% off your next visit and the person you refer will receive 15% off their first visit.
Botox, Brotox, and Dermal Fillers
- Purchase 30 units or more of Botox Cosmetic and save $50
- New dermal filler patients: save $100 on any full syringe of Juvederm with the Brilliant Distinctions program
- Rejuvenate under your eye with a full syringe of Teosyal Redensity II and save $100
- Refer a new client to enjoy an injectable treatment and you will receive 10% off your next visit and the person you refer will receive 10% off their first visit
In this video, Dr. Mitchell Brown discusses cellulite: how it is formed, whether lifestyle changes can help, and surgical treatment options, including Cellfina.
Cellfina is an FDA and Health Canada-approved treatment for cellulite that has been shown to produce results that last for at least two years. Book a consultation with Dr. Brown to determine if you are a candidate for Cellfina.
Dr Brown was one of the invited international faculty and gave several presentations that included topics on breast implant selection, the use of fat in aesthetic breast surgery and, developing a successful transgender breast program.
One of the most unique aspects of this meeting is the live surgery component, in which surgeons are invited to perform surgery that is broadcast in to the auditorium to the symposium participants. This year, Dr Brown was asked to perform a trans gender breast augmentation on a trans female patient who came to Atlanta with Dr Brown from the TRS (transition related surgery) Program in Toronto. The surgery was very successful, but most impactful, our wonderful patient was able to share the important moments in her transition story with the surgeons in attendance and explain some of the unique challenges that exist during the journey.
If you are a trans female thinking about breast augmentation, here are some things to consider:
- The rib cage and breasts of a trans woman are usually wider than that of a cis woman of similar height and weight. To create an ideal breast shape and to have that breast fit on the chest wall means that the surgeon must take multiple, precise measurements, and select from a wide range of implants. While this “dimensional planning” is important in all breast augmentations, it is particularly important in the trans female patient.
- A trans woman’s nipples are usually situated more to the outside of the breast mound. This affects where the implant should be placed so that the nipple ends up relatively centered on the breast mound.
- A trans woman’s nipples are also usually situated low on the breast mound. The ideal breast has about 55% of the breast volume below the plane of the nipple and 45% above. While sometimes the implant needs to be placed below the natural crease of the breast in a cisgender woman to achieve that balance, it is necessary far more often in the transgender patient. That position is critical to the result and must be planned exactly. Failure to properly determine where to situate the bottom of the breast and to keep the implant in that position are the two factors that account for most of the suboptimal results in transgender breast augmentation.
- Trans patients usually have thicker and tighter skin. Years of fluctuating breast size from monthly periods, weight changes, gravity, genetically thinner skin, and of course the substantial stretch with pregnancy can all thin skin further. This tighter skin often results in breasts that are somewhat fuller and perkier, especially in the upper portion of the breast.
- The pectoralis major muscle is often (but not always) thicker in a trans woman. Rarely is it thick enough to create a problem; it just requires a greater level of attention to anesthetic and technical considerations during surgery. There may be a greater tendency for the muscle to push the implants slightly down and out over time, though this also can be an issue for cisgender patients.
For more information about transition related surgery please visit Transition-Related Procedures.
Dr. Mitchell Brown and Dr. Ron Somogyi, Toronto Plastic Surgery
Recently, there has been a surge in media attention regarding implantable medical devices. Coverage has focussed on regulatory agencies, the process for device approval, device safety as well as the importance of collecting accurate post-approval data on adverse events and outcomes. Many devices were discussed including pacemakers, hip and knee implants, cardiac stents, pelvic meshes as well as breast implants. One area of discussion has centered around breast implants and a possible link to a type of lymphoma called ALCL.
A great deal of research has been published regarding breast implants and cancer. We can say quite conclusively that breast implants do not cause breast cancer. For the past several years there have been published cases of women diagnosed with a rare type of lymphoma in the fluid or tissue surrounding a breast implant. This entity has been named BIA-ALCL (Breast Implant Associated Anaplastic Large Cell Lymphoma). ALCL itself is a cancer of the immune system and more commonly occurs in people who have never undergone breast implant surgery. Estimated rates of ALCL is approximately 1 in 10,000 people in the general population.
At present, there are approximately 600 cases of BIA-ALCL reported worldwide and it is estimated that more than 10 million women have undergone breast implant surgery. To date, all cases of BIA-ALCL have been in association with breast implants that have a textured surface. The current lifetime risk with a textured implant is estimated to be 1:3800 – 1:30000. There is no risk of developing BIA-ALCL with smooth surfaced implants. It is important to know that all implants used at Toronto Plastic Surgery are fully approved by Health Canada as well as the FDA in the United States.
In the majority of reported cases, the initial presenting symptom is a distinct swelling of the affected breast. You would notice this as a substantial size change on the affected side. The breast might feel tense and firm. Usually the swelling comes on fairly rapidly, over several days or weeks, not over months or years. Typically, this occurs on one side only, but in exceptional cases, it can occur in both breasts.
If a person with breast implants notices any of these changes or symptoms, the appropriate action is to contact their surgeon for a follow-up visit. There are some very simple investigations that can be done to determine whether or not a person has BIA- ALCL. When detected early, it is very treatable.
It is important for you to know that both Dr. Somogyi and I have collectively been involved with the use of breast implants for over thirty years. We have followed our patients carefully and have published our experience on the safe use of breast implants and breast implant outcomes. We both attend medical conferences regularly and often participate as educators at these events. We want you to know that we stay up to date on the latest literature surrounding breast implants and breast implant safety.
In addition, it has always been our practice to encourage patients with any breast implant to return for regular follow up at least every 2-3 years. This is important so that we may inform you about new information or changes regarding breast implant technology and safety. Occasional assessment is recommended.
As new information becomes available regarding BIA-ALCL and breast implant safety, we will do our best to keep you informed. If you have any questions regarding breast implant surgery at Toronto Plastic Surgery, please feel free to contact us directly.